Michael McCleod
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Gastric Cancer Management and Outcomes
Papers in
- Oncology 36
- Lung Cancer Research Studies 13
- Cancer Immunotherapy and Biomarkers 12
- Cancer Treatment and Pharmacology 7
- Colorectal Cancer Treatments and Studies 5
-
- Lung Cancer Treatments and Mutations 19
- Lung Cancer Diagnosis and Treatment 7
- Co-authors
- Taral Patel (5 shared papers)Fairooz F. Kabbinavar (3 shared papers)William Novotny (3 shared papers)J. Randolph Hecht (3 shared papers)B. Nelson (1 shared paper)John Hamm (1 shared paper)Joseph J. Schulz (1 shared paper)R. Mass (1 shared paper)
- Journals
- Journal of Clinical Oncology (15 papers)Annals of Oncology (7 papers)Journal of Thoracic Oncology (3 papers)Lung Cancer (3 papers)Cancer Research (2 papers)
- Partner nations
- United StatesGermanyItaly
In The Last Decade
Michael McCleod
42 papers receiving 3.0k citations
Michael McCleod's Hit Papers
Peers
Comparison fields: 5 of 73
- Oncology 2.1k
- Pulmonary and Respiratory Medicine 1.1k
- Hepatology 151
- Cancer Research 201
- Immunology 289
Countries citing papers authored by Michael McCleod
This map shows the geographic impact of Michael McCleod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael McCleod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael McCleod more than expected).
Fields of papers citing papers by Michael McCleod
This network shows the impact of papers produced by Michael McCleod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael McCleod. The network helps show where Michael McCleod may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael McCleod, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial Hit paper breakdown → | 2019 | 1183 |
| 2 | Addition of Bevacizumab to Bolus Fluorouracil and Leucovorin in First-Line Metastatic Colorectal Cancer: Results of a Randomized Phase II Trial Hit paper breakdown → | 2005 | 743 |
| 3 | Cetuximab and First-Line Taxane/Carboplatin Chemotherapy in Advanced Non–Small-Cell Lung Cancer: Results of the Randomized Multicenter Phase III Trial BMS099 Hit paper breakdown → | 2010 | 353 |
| 4 | 2020 | 121 | |
| 5 | 2016 | 112 | |
| 6 | 2007 | 72 | |
| 7 | 2017 | 58 | |
| 8 | 2018 | 49 | |
| 9 | 2017 | 39 | |
| 10 | 2011 | 37 | |
| 11 | 2017 | 35 | |
| 12 | 2019 | 32 | |
| 13 | 2004 | 28 | |
| 14 | 2018 | 23 | |
| 15 | 2010 | 20 | |
| 16 | 2011 | 19 | |
| 17 | 2006 | 17 | |
| 18 | 1995 | 17 | |
| 19 | 2008 | 16 | |
| 20 | 2016 | 16 |
About Michael McCleod
Michael McCleod is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Epidemiology, Molecular Biology and Hepatology, having authored 44 papers that have together received 3.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (19 papers), Lung Cancer Research Studies (13 papers), Cancer Immunotherapy and Biomarkers (12 papers), Cancer Treatment and Pharmacology (7 papers), Lung Cancer Diagnosis and Treatment (7 papers), Colorectal Cancer Treatments and Studies (5 papers), Neuroendocrine Tumor Research Advances (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). The work is most often cited by research in Oncology (2.1k citations), Pulmonary and Respiratory Medicine (1.1k citations), Hepatology (151 citations), Cancer Research (201 citations) and Immunology (289 citations). Michael McCleod has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Taral Patel, Fairooz F. Kabbinavar, William Novotny, J. Randolph Hecht, B. Nelson, John Hamm, Joseph J. Schulz, R. Mass, Niels Reinmuth and Maen Hussein. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Journal of Thoracic Oncology, Lung Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.